Multisystem inflammatory syndrome in children in Canada
This article provides a summary of the epidemiology of multisystem inflammatory syndrome in children (MIS-C) cases reported nationally in Canada by provincial and territorial health authorities. Multisystem inflammatory syndrome in children is a post-viral inflammatory syndrome that temporally follows coronavirus disease 2019 (COVID-19). Symptoms may include fever, abdominal pain, vomiting, diarrhea, skin rash and other signs of inflammation. In Canada, MIS-C is rare, with 269 cases reported to the Public Health Agency of Canada between March 11, 2020 and October 2, 2021. One hundred forty-two (53%) of these cases were lab-confirmed COVID-19 cases or epidemiologically-linked with COVID-19 cases. Cases have been reported in infants as young as one week to youth as old as 18 years, with a median age of six years. Cases were more likely to occur in males than females (58% vs 42%, respectively; p=0.006). Almost all MIS-C cases (99%) required hospitalization and 36% required intensive care unit admission. No deaths have been reported to date. The time trend of MIS-C aligns with the incidence rate time trend of COVID-19 reported in children, with a two to six-week lag.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Canada communicable disease report = Releve des maladies transmissibles au Canada - 47(2021), 11 vom: 10. Nov., Seite 461-465 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Laverty, Meghan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 01.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.14745/ccdr.v47i11a03 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338860932 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338860932 | ||
| 003 | DE-627 | ||
| 005 | 20231226001624.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14745/ccdr.v47i11a03 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1129.xml |
| 035 | |a (DE-627)NLM338860932 | ||
| 035 | |a (NLM)35356073 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Laverty, Meghan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multisystem inflammatory syndrome in children in Canada |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.04.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a This article provides a summary of the epidemiology of multisystem inflammatory syndrome in children (MIS-C) cases reported nationally in Canada by provincial and territorial health authorities. Multisystem inflammatory syndrome in children is a post-viral inflammatory syndrome that temporally follows coronavirus disease 2019 (COVID-19). Symptoms may include fever, abdominal pain, vomiting, diarrhea, skin rash and other signs of inflammation. In Canada, MIS-C is rare, with 269 cases reported to the Public Health Agency of Canada between March 11, 2020 and October 2, 2021. One hundred forty-two (53%) of these cases were lab-confirmed COVID-19 cases or epidemiologically-linked with COVID-19 cases. Cases have been reported in infants as young as one week to youth as old as 18 years, with a median age of six years. Cases were more likely to occur in males than females (58% vs 42%, respectively; p=0.006). Almost all MIS-C cases (99%) required hospitalization and 36% required intensive care unit admission. No deaths have been reported to date. The time trend of MIS-C aligns with the incidence rate time trend of COVID-19 reported in children, with a two to six-week lag | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a MIS-C | |
| 650 | 4 | |a children’s health | |
| 650 | 4 | |a inflammatory syndrome | |
| 650 | 4 | |a surveillance | |
| 700 | 1 | |a Salvadori, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Squires, Susan G |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmed, May |e verfasserin |4 aut | |
| 700 | 1 | |a Eisenbeis, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Santina |e verfasserin |4 aut | |
| 700 | 1 | |a Des Cormiers, Annick |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Y Anita |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Canada communicable disease report = Releve des maladies transmissibles au Canada |d 1994 |g 47(2021), 11 vom: 10. Nov., Seite 461-465 |w (DE-627)NLM012649449 |x 1188-4169 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:11 |g day:10 |g month:11 |g pages:461-465 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.14745/ccdr.v47i11a03 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 11 |b 10 |c 11 |h 461-465 | ||